116 related articles for article (PubMed ID: 29158682)
1. UNBS5162 inhibits proliferation of human retinoblastoma cells by promoting cell apoptosis.
Wang B; Shen J; Wang J
Onco Targets Ther; 2017; 10():5303-5309. PubMed ID: 29158682
[TBL] [Abstract][Full Text] [Related]
2. UNBS5162 inhibits SKOV3 ovarian cancer cell proliferation by regulating the PI3K/AKT signalling pathway.
Wang Q; Shi W
Oncol Lett; 2019 Mar; 17(3):2976-2982. PubMed ID: 30854075
[TBL] [Abstract][Full Text] [Related]
3. UNBS5162 as a novel naphthalimide holds efficacy in human gastric carcinoma cell behaviors mediated by AKT/ERK signaling pathway.
Li HH; Song XX; Liu B; Yang WP
Drug Dev Ind Pharm; 2019 Aug; 45(8):1306-1312. PubMed ID: 30995142
[No Abstract] [Full Text] [Related]
4. UNBS5162 inhibits the proliferation of human A549 non-small-cell lung cancer cells by promoting apoptosis.
Liu C; Xing J; Gao Y
Thorac Cancer; 2018 Jan; 9(1):105-111. PubMed ID: 29130641
[TBL] [Abstract][Full Text] [Related]
5. UNBS5162 inhibits colon cancer growth via suppression of PI3K/Akt signaling pathway.
Zhang F; Lv HZ; Liu JM; Ye XY; Wang CC
Med Sci (Paris); 2018 Oct; 34 Focus issue F1():99-104. PubMed ID: 30403183
[TBL] [Abstract][Full Text] [Related]
6. UNBS5162 inhibits the proliferation of esophageal cancer squamous cells via the PI3K/AKT signaling pathway.
He D; Zhang S
Mol Med Rep; 2018 Jan; 17(1):549-555. PubMed ID: 29115622
[TBL] [Abstract][Full Text] [Related]
7. UNBS5162 and amonafide inhibits tumor progression in human melanoma by the AKT/mTOR pathway.
Ye Y; Huang S; Wu Y
Cancer Manag Res; 2019; 11():2339-2348. PubMed ID: 30962721
[TBL] [Abstract][Full Text] [Related]
8. UNBS5162 induces growth inhibition and apoptosis via inhibiting PI3K/AKT/mTOR pathway in triple negative breast cancer MDA-MB-231 cells.
Yue X; Li M; Chen D; Xu Z; Sun S
Exp Ther Med; 2018 Nov; 16(5):3921-3928. PubMed ID: 30344670
[TBL] [Abstract][Full Text] [Related]
9. UNBS5162 inhibits proliferation of human melanoma cells by inducing apoptosis via the PI3K/Akt pathway.
Shi X; Yang L; Xie J; Zhao Y; Cong J; Li Z; Li H; Cheng X; Fan J
Mol Med Rep; 2018 Sep; 18(3):3382-3388. PubMed ID: 30066877
[TBL] [Abstract][Full Text] [Related]
10. Tetramethylpyrazine downregulates transcription of the CXC receptor 4 (CXCR4) via nuclear respiratory factor‑1 (Nrf‑1) in WERI‑Rb1 retinoblastoma cells.
Wu N; Yang Y; Yu N; Wu Y; Han X; Chen S; Zhang J; Chen X; Wu C; Yang M; Qiu J; Ge J; Yu K; Zhuang J
Oncol Rep; 2019 Sep; 42(3):1214-1224. PubMed ID: 31322174
[TBL] [Abstract][Full Text] [Related]
11. Phenoxazine derivative, 2-amino-4,4alpha-dihydro-4alpha,7-dimethyl-3H-phenoxazine-3-one suppresses growth of human retinoblastoma cell line Y79 in vitro and in vivo.
Kimura K; Usui Y; Hattori T; Yamakawa N; Goto H; Usui M; Okada S; Shirato K; Tomoda A
Oncol Rep; 2008 Jan; 19(1):3-10. PubMed ID: 18097569
[TBL] [Abstract][Full Text] [Related]
12. UNBS5162, a novel naphthalimide that decreases CXCL chemokine expression in experimental prostate cancers.
Mijatovic T; Mahieu T; Bruyère C; De Nève N; Dewelle J; Simon G; Dehoux MJ; van der Aar E; Haibe-Kains B; Bontempi G; Decaestecker C; Van Quaquebeke E; Darro F; Kiss R
Neoplasia; 2008 Jun; 10(6):573-86. PubMed ID: 18516294
[TBL] [Abstract][Full Text] [Related]
13. Rapamycin inhibits proliferation and apoptosis of retinoblastoma cells through PI3K/AKT signaling pathway.
Yao J; Xu M; Liu Z
Oncol Lett; 2020 Apr; 19(4):2950-2956. PubMed ID: 32218850
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA CCAT1 promotes human retinoblastoma SO-RB50 and Y79 cells through negative regulation of miR-218-5p.
Zhang H; Zhong J; Bian Z; Fang X; Peng Y; Hu Y
Biomed Pharmacother; 2017 Mar; 87():683-691. PubMed ID: 28088735
[TBL] [Abstract][Full Text] [Related]
15. Antiproliferative and apoptotic effects of indomethacin on human retinoblastoma cell line Y79 and the involvement of β-catenin, nuclear factor-κB and Akt signaling pathways.
Zheng Q; Zhang Y; Ren Y; Wu Y; Yang S; Zhang Y; Chen H; Li W; Zhu Y
Ophthalmic Res; 2014; 51(2):109-15. PubMed ID: 24355977
[TBL] [Abstract][Full Text] [Related]
16. Anti-proliferation and apoptosis-inducing effects of sodium aescinate on retinoblastoma Y79 cells.
Li L; Xu B; Li CR; Zhang MM; Wu SJ; Dang WJ; Liu JC; Sun SG; Zhao W
Int J Ophthalmol; 2020; 13(10):1546-1553. PubMed ID: 33078103
[TBL] [Abstract][Full Text] [Related]
17. Piperlongumine inhibits proliferation and oncogenic MYCN expression in chemoresistant metastatic retinoblastoma cells directly and through extracellular vesicles.
Shi C; Huang K; Soto J; Sankaran R; Kalia V; Onwumere O; Young M; Einbond L; Redenti S
Biomed Pharmacother; 2023 May; 161():114554. PubMed ID: 36940616
[TBL] [Abstract][Full Text] [Related]
18. Quinoline-Based Compound BPIQ Exerts Anti-Proliferative Effects on Human Retinoblastoma Cells via Modulating Intracellular Reactive Oxygen Species.
Cheng KC; Hung CT; Chen KJ; Wu WC; Suen JL; Chang CH; Lu CY; Tseng CH; Chen YL; Chiu CC
Arch Immunol Ther Exp (Warsz); 2016 Apr; 64(2):139-47. PubMed ID: 26564153
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of circular RNA hsa_circ_0001649 indicates poor prognosis for retinoblastoma and regulates cell proliferation and apoptosis via AKT/mTOR signaling pathway.
Xing L; Zhang L; Feng Y; Cui Z; Ding L
Biomed Pharmacother; 2018 Sep; 105():326-333. PubMed ID: 29864621
[TBL] [Abstract][Full Text] [Related]
20. Tetramethylpyrazine-mediated regulation of CXCR4 in retinoblastoma is sensitive to cell density.
Wu N; Xu L; Yang Y; Yu N; Zhang Z; Chen P; Zhang J; Tang M; Yuan M; Ge J; Yu K; Zhuang J
Mol Med Rep; 2017 May; 15(5):2481-2488. PubMed ID: 28447713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
